|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date20 Dec 2024 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United Kingdom |
First Approval Date15 Nov 2023 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date02 Jul 2015 |
100 Clinical Results associated with Vertex Pharmaceuticals (Europe) Ltd. (Ireland)
0 Patents (Medical) associated with Vertex Pharmaceuticals (Europe) Ltd. (Ireland)
100 Deals associated with Vertex Pharmaceuticals (Europe) Ltd. (Ireland)
100 Translational Medicine associated with Vertex Pharmaceuticals (Europe) Ltd. (Ireland)